ArticleHealth economics review2012

Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective.

Jan Zeidler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.